Buscar
Virax Biolabs Group Ltd
VRAXAñadir a la lista de seguimiento
2.620USD
-0.180-6.43%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
11.38MCap. mercado
PérdidaP/E TTM
Más Datos de Virax Biolabs Group Ltd Compañía
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The Company is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).
Información de Virax Biolabs Group Ltd
Símbolo de cotizaciónVRAX
Nombre de la empresaVirax Biolabs Group Ltd
Fecha de salida a bolsaJul 14, 2022
Director ejecutivoFoster (James)
Número de empleados19
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 14
DirecciónBiocity Glasgow
CiudadLONDON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited Kingdom
Código postalML1 5UH
Teléfono4402077887414
Sitio Webhttps://www.viraxbiolabs.com
Símbolo de cotizaciónVRAX
Fecha de salida a bolsaJul 14, 2022
Director ejecutivoFoster (James)
Ejecutivos de Virax Biolabs Group Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. James Foster
Mr. James Foster
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
16.61K
+30.65%
Mr. Evan Norton
Mr. Evan Norton
Independent Director
Independent Director
880.00
+30.34%
Mr. Nelson M. Haight
Mr. Nelson M. Haight
Independent Director
Independent Director
--
--
Dr. Nigel Mccracken, Ph.D.
Dr. Nigel Mccracken, Ph.D.
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Dr. Iain Miller
Dr. Iain Miller
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. James Foster
Mr. James Foster
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
16.61K
+30.65%
Mr. Evan Norton
Mr. Evan Norton
Independent Director
Independent Director
880.00
+30.34%
Mr. Nelson M. Haight
Mr. Nelson M. Haight
Independent Director
Independent Director
--
--
Dr. Nigel Mccracken, Ph.D.
Dr. Nigel Mccracken, Ph.D.
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Dr. Iain Miller
Dr. Iain Miller
Independent Director
Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Virax Biolabs Group Ltd?
Los cinco principales accionistas de Virax Biolabs Group Ltd son: Mr. James Foster
¿Cuántas instituciones poseen acciones de Virax Biolabs Group Ltd (VRAX)?
A fecha de 2026Q1, 22 instituciones poseen acciones de Virax Biolabs Group Ltd, con un valor de mercado combinado de aproximadamente 851.39K, lo que representa el 4.27% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 268600.00.